Sciatica Treatment Market Expected to Reach $991.3 Million by 2031—Allied Market Research

According to a new report published by Allied Market Research, titled, “Sciatica Treatment Market," The sciatica treatment market size was valued at $678.02 million in 2021, and is estimated to reach $991.3 million by 2031, growing at a CAGR of 3.9% from 2022 to 2031.

Sciatica is one of the most common causes for lower back and leg pain in population around the globe. It is mainly caused due to compression of the sciatic nerve which radiates into the buttocks, legs, ankles, or feet. Sciatica can be of different types which include genetic sciatica, chronic sciatica, acute sciatica, peripheral neuropathy sciatica and others. Sciatica cannot be treated completely; its symptoms can be reduced using medications prescribed by the healthcare provider according to the condition. Sciatica treatment includes drugs belonging to the class NSAIDs, steroids, antidepressants, anticonvulsants, and others.  

Furthermore, various factors that are driving the growth of the sciatica treatment market are increase in prevalence of lower back pain conditions, advances in manufacturing and development of medications, and rise in awareness about sciatica treatment in population. Moreover, there has been a huge advancement in healthcare sector, owing to increase in research activities carried out by the scientist and researchers in the field of pharmaceuticals. Also, the key market players in pharmaceutical and medical device industries are upgrading the existing product portfolio with some new innovations, which makes the treatment of conditions easier and comfortable. There is a huge adoption of advanced technologies for manufacturing of medications, to enhance quality of the product. Similar advancements are witnessed in sciatica treatment field, which leads to increase in sales of sciatica treatment products, and thus propels the growth of the market.In addition, increase in geriatric populations drives the growth of the market. People worldwide are living longer and expect to live into lives up to sixties and beyond.  

Moreover, every country in the world is experiencing growth with regards to the size and proportion of older persons in the population. For instance, according to the World Health Organization, by 2030, 1 in 6 people in the world will be aged 60 years or over. At this time the share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion. The elderly people are more prone to a variety of health conditions especially joints and back pain conditions such as sciatica. Thus, there is a huge demand for sciatica treatment medications, for treating elderly sciatica and is also the upcoming sciatica treatment market trends. Moreover, surgical treatments are mainly avoided for treating sciatica in aged people, which also boosts the demand for medications. This, in turn, fosters the sciatica treatment market growth. 

On the basis of type, the market is bifurcated into acute sciatica, chronic sciatica and others. The chronic sciatica segment exhibited the highest sciatica treatment market size in 2021, and is expected to grow at the fastest rate during the forecast period, owing to increase in incidences of chronic sciatica and rise in geriatric population which is more prone to chronic back pain conditions including sciatica.  

On the basis of drug class, the market is classified into non-steroidal anti-inflammatory drug (NSAIDs), steroids, antidepressants, and others. The non-steroidal anti-inflammatory drug (NSAIDs) segment dominated the sciatica treatment market share in 2021, and expected to grow at the fastest rate during the forecast period, owing to the increase in adoption and prescription of NSAIDs by many healthcare professionals for sciatica pain management around the globe.On the basis of distribution channel, the market is segmented into hospital pharmacies, retail and specialty pharmacies and online providers. The retail and specialty pharmacies segment exhibited highest growth in 2021, owing to increase in number of retail and specialty pharmacies around the globe, and due to easy availability of OTC medications in the drug store.  

On the other hand, online providers segment is anticipated to grow at the fastest rate owing to easy accessibility of medications and doors step delivery services.Region wise, North America obtained the highest market share in 2021, owing to the rise in incidences of sciatica due to increase in prevalence of conditions such as spinal stenosis and others. On the other hand, Asia-Pacific is expected to witness highest growth during the forecast period, owing to factors such as rise in investments in manufacturing of high-quality products by major key players, and availability of raw materials for manufacturing of sciatica treatment medications. 

Key findings of the study 

• By type, the chronic sciatica segment was highest contributor to the sciatica market in 2021. 
• By drug class, non-steroidal anti-inflammatory drug (NSAIDs) segment dominated the sciatica treatment industry in 2021 and is anticipated to grow at the highest CAGR during the forecast period 
• By distribution channel, the retail and specialty pharmacies segment dominated the market in 2021. However, online providers segment is anticipated to grow at the highest CAGR during the forecast period. 
• Region wise, North America generated the largest revenue in 2021. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.